Tiigimäe-Saar, Janne <br/><br/>
Saliva changes in Parkinson's disease patients after injection of Botulinum neurotoxin type A.  [electronic resource] 

 -  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology  May 2018 
 - 871-877 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1590-3478 
<br/><br/><label>Standard No.: </label>10.1007/s10072-018-3279-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antiparkinson Agents<br/>Botulinum Toxins, Type A--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Neuromuscular Agents--therapeutic use<br/>Parkinson Disease--complications<br/>Saliva--drug effects<br/>Salivary Glands--diagnostic imaging<br/>Sialorrhea--drug therapy<br/>Treatment Outcome<br/>Ultrasonography